SCHEMBL4297417

SCHEMBL4297417

CC(C)(C)OC(=O)NC1CCNCC1.Cc1nc(C=O)nc2c1CCC(=O)N2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 2/20 0.33
GAA P10253 1/20 0.33
SMYD3 Q9H7B4 1/20 0.32
CKS1B P61024 1/20 0.31
SKP1 P63208 1/20 0.31
SKP2 Q13309 1/20 0.31
KDM1A O60341 1/20 0.31
MAOB P27338 1/20 0.31
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
PIM1 P11309 2/20 0.31
PIM2 Q9P1W9 2/20 0.31
PIM3 Q86V86 1/20 0.30
PARP1 P09874 1/20 0.30
EPHX2 P34913 1/20 0.30
PIK3CA P42336 1/20 0.30
MTOR P42345 1/20 0.30
PRKDC P78527 1/20 0.30
DRD2 P14416 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4294766 0.90 BTK (0.33) BTKGAASMYD3CKS1BSKP1
SCHEMBL4302615 0.89 BTK (0.32) BTKGAASMYD3CKS1BSKP1
SCHEMBL4302688 0.82 SMYD3 (0.40) BTKGAASMYD3CKS1BSKP1
Formic Acid SCHEMBL7216484 0.71 BTK (0.48) BTKGAAKDM1AMAOBEPHX2
SCHEMBL56856 0.71 EPHX1 (0.53) BTKGAAKDM1AMAOBEPHX2
SCHEMBL4296620 0.70 GAA (0.37) GAASMYD3CKS1BSKP1SKP2
SCHEMBL4304869 0.70 PIM1 (0.35) BTKSMYD3CKS1BSKP1SKP2
Ammonia Solution, Strong SCHEMBL15021680 0.70 EPHX1 (0.52) BTKGAAKDM1AMAOBEPHX2
Hydrochloric Acid SCHEMBL4158527 0.70 EPHX1 (0.52) BTKGAAKDM1AMAOBEPHX2
Water SCHEMBL27795194 0.70 EPHX1 (0.52) BTKGAAKDM1AMAOBEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071592-B2 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2011-12-06 US disclosed
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES ETFA, NQO2, GNAQ BTK 2070/4885GAA 1815/4885SMYD3 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.